SCHEMBL483304

SCHEMBL483304

C=COC(=O)NCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
CYP2D6 P10635 2/20 0.50
CYP2C19 P33261 2/20 0.50
LMNA P02545 1/20 0.50
GAA P10253 1/20 0.49
BCHE P06276 1/20 0.48
KMT2A Q03164 2/20 0.47
HPGD P15428 2/20 0.47
MMP1 P03956 1/20 0.47
MMP2 P08253 1/20 0.47
MMP9 P14780 1/20 0.47
CYP2C9 P11712 2/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
TSHR P16473 1/20 0.47
CASP1 P29466 1/20 0.47
EPHX1 P07099 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21121950 0.84 ALDH1A1 (0.51) ALDH1A1CYP2D6CYP2C19LMNAGAA
SCHEMBL1415937 0.82 EPHX2 (0.51) ALDH1A1CYP2D6CYP2C19LMNAGAA
SCHEMBL2095021 0.79 GAA (0.53) ALDH1A1CYP2D6CYP2C19LMNAGAA
SCHEMBL31492474 0.79 ALDH1A1 (0.49) ALDH1A1CYP2D6CYP2C19LMNAGAA
SCHEMBL7624194 0.79 CASP1 (0.68) ALDH1A1CYP2D6CYP2C19LMNACASP1
SCHEMBL8621389 0.77 GAA (0.55) ALDH1A1CYP2D6CYP2C19LMNAGAA
SCHEMBL1720194 0.77 ALDH1A1 (0.67) ALDH1A1CYP2D6CYP2C19GAABCHE
SCHEMBL29665196 0.76 BCHE (0.53) ALDH1A1CYP2D6CYP2C19LMNAGAA
SCHEMBL1415939 0.76 PLAU (0.52) ALDH1A1CYP2D6CYP2C19GAABCHE
SCHEMBL23349345 0.76 THRB (0.56) ALDH1A1CYP2D6CYP2C19LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116396650-A Ink-absorbing coating 吉安天晟新材料有限公司 2023-07-07 CN claimed
CN-111171210-A Tetrafluoroethylene-alkenyl carbamate-perfluoroalkyl vinyl ether dispersion resin and microporous membrane prepared therefrom 苏州世华新材料科技股份有限公司 2020-05-19 CN claimed
CN-112823037-B Inhibition of deubiquitinase USP25 and USP28 瓦洛健康股份有限公司 2023-12-19 CN disclosed
CN-116396650-A Ink-absorbing coating 吉安天晟新材料有限公司 2023-07-07 CN disclosed
CN-112939815-A Carbamate containing terminal double bonds, preparation method thereof and polymer 贵州大学 2021-06-11 CN disclosed
CN-112823037-A Inhibition of deubiquitinase USP25 and USP28 瓦洛早期发现股份有限公司 2021-05-18 CN disclosed
CN-108440230-B Preparation method of olefin and method for synthesizing Chondriamidea and ChondriamideC 中国科学技术大学 2021-03-09 CN disclosed
CN-111171210-A Tetrafluoroethylene-alkenyl carbamate-perfluoroalkyl vinyl ether dispersion resin and microporous membrane prepared therefrom 苏州世华新材料科技股份有限公司 2020-05-19 CN disclosed
US-8604030-B2 Fused piperidine compound and pharmaceutical containing same KOWA COMPANY, LTD. (JP) 2013-12-10 US disclosed
US-20120108581-A1 FUSED PIPERIDINE COMPOUND AND PHARMACEUTICAL CONTAINING SAME KOWA COMPANY, LTD (JP) 2012-05-03 US disclosed
EP-2412710-A1 FUSED PIPERIDINE COMPOUND AND PHARMACEUTICAL AGENT COMPRISING SAME Kowa Company, Ltd. (JP) 2012-02-01 EP disclosed
CN-101616897-A The ethylamino-phenyl derivatives that heterocyclic radical replaces, its preparation and as the purposes of medicament ESTEVE LABOR DR 2009-12-30 CN disclosed
US-20090005354-A1 New Amino Derivatives and Their Use as Pharmaceuticals PFIZER, INC. (US) 2009-01-01 US disclosed
EP-1758862-A1 AMINOPYRIDINE DERIVATIVES AS SELECTIVE DOPAMINE D3 AGONISTS Pfizer Limited (GB) 2007-03-07 EP disclosed
US-20050288270-A1 New aminopyridine derivatives and their use as pharmaceuticals PFIZER INC 2005-12-29 US disclosed
WO-2005115985-A1 AMINOPYRIDINE DERIVATIVES AS SELECTIVE DOPAMINE D3 AGONISTS PFIZER LIMITED (GB) 2005-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288270-A1 New aminopyridine derivatives and their use as pharmaceuticals DRD2, DRD1, DRD3 ALDH1A1 792/4885CYP2D6 785/4885CYP2C19 304/4885
US-20120108581-A1 FUSED PIPERIDINE COMPOUND AND PHARMACEUTICAL CONTAINING SAME EPOR, JAK2, HBZ ALDH1A1 360/4885CYP2D6 445/4885CYP2C19 616/4885
US-20090005354-A1 New Amino Derivatives and Their Use as Pharmaceuticals DRD2, DRD1, DRD3 ALDH1A1 1067/4885CYP2D6 823/4885CYP2C19 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.